Literature DB >> 15056802

Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes.

Judy L Raucy1, Jerome Lasker, Kazuaki Ozaki, Veronica Zoleta.   

Abstract

CYP2E1 and CYP4A11 are cytochrome P450 enzymes that are regulated by physiological conditions including diabetes and fasting. In addition, the xenochemical clofibrate has been reported to induce both rodent CYP2E1 and CYP4A. These findings suggest similar modes of regulation. Also in common to both enzymes is the ability to metabolize fatty acids such as laurate and arachidonic acid. Here, we used primary cultures of human hepatocytes to determine if certain xenochemicals could regulate CYP2E1 and CYP4A11. Ethanol significantly (p < 0.05) increased expression of CYP2E1 mRNA by 216 +/- 32% of control, but did not alter CYP4A11 mRNA accumulation (145 +/- 22% of control). In contrast, hepatocytes exposed to ethanol exhibited only a slight elevation in CYP2E1 protein (122 +/- 13% of control) and a negligible effect on CYP4A11 protein. Clofibrate significantly (p < 0.05) enhanced both CYP4A11 mRNA and protein by 239 +/- 30% and 154 +/- 10% of control, respectively, but did not increase CYP2E1. Because rodent CYP4A is reportedly regulated by fatty acids through peroxisome proliferator activated receptor alpha (PPARalpha) and CYP2E1 is induced by high fat diets, we examined the effects of a medium chain fatty acid, palmitate on CYP2E1 mRNA content. Palmitic acid significantly (p < 0.05) increased CYP2E1 mRNA to 326 +/- 57% of control. Collectively, results presented here identify agents that enhance CYP2E1 and CYP4A11 at the transcription level and suggest that fatty acids may represent a similar mode of regulation for these P450 enzymes. The lack of induction of CYP2E1 protein by ethanol in human hepatocytes indicates that for certain P450 enzymes, isolated hepatocytes may not be an adequate tool for predicting in vivo responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056802     DOI: 10.1093/toxsci/kfh126

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  18 in total

1.  Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages.

Authors:  Mengyao Jin; Priyanka Arya; Kalpeshkumar Patel; Bhupendra Singh; Peter S Silverstein; Hari K Bhat; Anil Kumar; Santosh Kumar
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

2.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

3.  Cytochrome P450 and gene activation--cholesterol elimination and regression of atherosclerosis: author reply to the commentary.

Authors:  Pauli V Luoma
Journal:  Eur J Clin Pharmacol       Date:  2008-09-25       Impact factor: 2.953

4.  Ascorbic acid is superior to silymarin in the recovery of ethanol-induced inflammatory reactions in hepatocytes of guinea pigs.

Authors:  P A Abhilash; R Harikrishnan; M Indira
Journal:  J Physiol Biochem       Date:  2013-05-08       Impact factor: 4.158

5.  PPARα is regulated by miR-21 and miR-27b in human liver.

Authors:  Katsuhiko Kida; Miki Nakajima; Takuya Mohri; Yuki Oda; Shingo Takagi; Tatsuki Fukami; Tsuyoshi Yokoi
Journal:  Pharm Res       Date:  2011-05-12       Impact factor: 4.200

6.  Establishment and characterization of feeder cell-dependent bovine fetal liver cell lines.

Authors:  Neil C Talbot; Ling Wang; Wesley M Garrett; Thomas J Caperna; Young Tang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-10       Impact factor: 2.416

Review 7.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 8.  Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

Authors:  Michael Sinz; Gillian Wallace; Jasminder Sahi
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

9.  Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?

Authors:  Jiang Yue; Renxiu Peng
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model.

Authors:  Uzen Savas; Daniel E W Machemer; Mei-Hui Hsu; Pryce Gaynor; Jerome M Lasker; Robert H Tukey; Eric F Johnson
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.